toripalimab axitinib in patients with metastatic mucosal melanoma
Published 4 years ago • 783 plays • Length 2:19Download video MP4
Download video MP3
Similar videos
-
11:50
phase ii trial of nivolumab and axitinib in anti-pd-1 refractory melanoma
-
0:49
scandium 2: ihp with ipilimumab and nivolumab in uveal melanoma metastases
-
36:56
beyond cutaneous: ocular and mucosal melanoma
-
1:17
dr. shoushtari on the role of nivolumab and ipilimumab in mucosal melanoma
-
1:21
treatment options for mucosal melanoma patients
-
32:34
mucosal melanoma: recent advances and future perspectives
-
1:59
checkmate 238: nivolumab versus ipilimumab in stage iii melanoma
-
7:41
nivolumab potentially superior to standard chemo in advanced melanoma
-
46:40
iclio webinar: therapeutic approaches to metastatic melanoma
-
1:20
pixatimod and nivolumab in metastatic melanoma, nsclc and mss crc
-
0:48
targeting c/ebpβ in melanoma
-
5:56
results from checkmate-032, nivolumab and ipilimumab for melanoma
-
1:28
dr. jeffery s. weber on sequencing of nivolumab, ipilimumab in metastatic melanoma
-
1:25
dr. ott discusses ipilimumab and nivolumab in melanoma
-
1:55
dr. jeffrey weber on ipilimumab for melanoma
-
1:22
dr. sznol discusses the combination of ipilimumab and nivolumab in melanoma
-
1:15
dr. postow on nivolumab combined with ipilimumab in melanoma
-
6:03
melanoma and cutaneous malignancies -- diagnosis, treatment & survivorship at penn medicine
-
0:50
dr. sondak on ipilimumab in melanoma